Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Garry M Walsh

Showing results (31-40 of 55) with videos related to

Pageof 6
Sort By:
Immunotherapy|November 6, 2013
An update on biologic-based therapy in asthmaGarry M Walsh
Current Opinion in Allergy and Clinical Immunology|June 26, 2015
Mepolizumab-based therapy in asthma: an updateGarry M Walsh
Current Medicinal Chemistry|October 5, 2006
Levocetirizine: an updateGarry M Walsh
Discovery Medicine|April 29, 2011
Novel cytokine-directed therapies for asthmaGarry M Walsh
Expert Review of Respiratory Medicine|September 9, 2018
Recent developments in the use of biologics targeting IL-5, IL-4, or IL-13 in severe refractory asthmaGarry M Walsh
Expert Opinion on Emerging Drugs|December 3, 2008
Emerging drugs for asthmaGarry M Walsh
Current Pharmaceutical Design|September 24, 2005
Novel therapies for asthma--advances and problemsGarry M Walsh
Current Opinion in Molecular Therapeutics|May 30, 2009
Reslizumab, a humanized anti-IL-5 mAb for the treatment of eosinophil-mediated inflammatory conditionsGarry M Walsh
Journal of Cell Death|October 4, 2014
Eosinophil apoptosis and clearance in asthmaGarry M Walsh
Expert Opinion on Pharmacotherapy|March 19, 2008
A review of the role of levocetirizine as an effective therapy for allergic diseaseGarry M Walsh
Pageof 6

Showing results (31-40 of 55) with videos related to

Sort By:
Pageof 6
Immunotherapy|November 6, 2013
An update on biologic-based therapy in asthmaGarry M Walsh
Current Opinion in Allergy and Clinical Immunology|June 26, 2015
Mepolizumab-based therapy in asthma: an updateGarry M Walsh
Current Medicinal Chemistry|October 5, 2006
Levocetirizine: an updateGarry M Walsh
Discovery Medicine|April 29, 2011
Novel cytokine-directed therapies for asthmaGarry M Walsh
Expert Review of Respiratory Medicine|September 9, 2018
Recent developments in the use of biologics targeting IL-5, IL-4, or IL-13 in severe refractory asthmaGarry M Walsh
Expert Opinion on Emerging Drugs|December 3, 2008
Emerging drugs for asthmaGarry M Walsh
Current Pharmaceutical Design|September 24, 2005
Novel therapies for asthma--advances and problemsGarry M Walsh
Current Opinion in Molecular Therapeutics|May 30, 2009
Reslizumab, a humanized anti-IL-5 mAb for the treatment of eosinophil-mediated inflammatory conditionsGarry M Walsh
Journal of Cell Death|October 4, 2014
Eosinophil apoptosis and clearance in asthmaGarry M Walsh
Expert Opinion on Pharmacotherapy|March 19, 2008
A review of the role of levocetirizine as an effective therapy for allergic diseaseGarry M Walsh
Pageof 6